Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal Oniris

Home page

Xenobio-TICK: Sequencing the tick transcriptome for development of new acaricides

On a global scale, ticks are the ectoparasites that have the most economic impact on livestock farming, have negative consequences on animal health and transmit numerous pathogens. In Europe, the impact of tick-borne diseases in cattle is more limited but their importance is reinforced by their zoonotic nature. Since livestock are prized by adult ticks (including the most common species in Europe, Ixodes ricinus, which also bites humans) for their blood meal, they are important hosts for human vector-borne diseases (including Lyme disease, the most common vector-borne disease in temperate regions of the Northern Hemisphere).

Until now, tick control has relied mainly on the use of chemical acaricides. These molecules can have negative effects on humans, livestock and ecosystems. In addition, resistance to acaricides has already been observed in ticks in different parts of the world. The emergence of resistance in ticks promotes the use of higher doses of acaricides and aggravates the problems associated with the unintended effects of acaricides. There is therefore a need to develop new acaricides that will target ticks very specifically and thus limit their unintended negative effects.

Objective of the Xenobio-TICK project
  • Deep sequencing of the tick transcriptome in order to identify and characterize new neuroreceptor genes, as divergent as possible from those of insects, which will be used as tick specific targets for the development of new acaricides.
  • After being identified using bioinformatics tools, these new neuroreceptors will be functionally characterized and their sensitivity to certain molecules will be studied. The genetic variability of these receptors will also be estimated in order to estimate the potential durability of the acaricide targeting this receptor. Although high-throughput screening of a large number of molecules is beyond the scope of Xenobio-TICK, this project, by making available functional and expressible neuronal receptors in heterologous systems, will be a major step forward in the development of automated screening of molecules targeting these receptors.

The project should enable the development of a collaboration with industrial partners for the development of new acaricides with high efficacy and less unintended effects.

The Xenobio-TICK project is an Institut Carnot France Futur Elevage project (ICF2E).
logo_FFE
Partners

UMR ISP (centre Inra Val de Loire)

USC LBLGC (Laboratoire de Biologie des Ligneux et des Grandes Cultures, centre Inra Val de Loire)